• Lectures •
Imaging study on the ductal carcinoma in situ of the breast
DOI:10.3969/j.issn.1674-8034.2012.02.004.
| [Abstract] The pathology and the imaging findings of ductal carcinoma in situ (DCIS) of the breast, including the manifestations in mammography, ultasonography, and magnetic resonance imaging (MRI), were described. The interventional procedures including localization of the microcalcifications with imaging guidance and needle core biopsy with stereotactic localization were also introduced in this paper. The author emphasized that the detection and diagnosis of DCIS needed a comprehensive imaging approach in the clinical setting. |
| [Keywords] Ductal carcinoma in situ；Breast；Microcalcifications；Imaging；Magnetic resonance imaging |
WANG Deng-bin * Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
*Correspondence to: Wang DB, E-mail:dbwang8@yahoo.com.cn
Conflicts of interest None.
| Received 2012-02-02 |
| Accepted 2012-03-05 |
| DOI: 10.3969/j.issn.1674-8034.2012.02.004 |
| DOI:10.3969/j.issn.1674-8034.2012.02.004. |
[1]
Bloodgood JC. Comedo-carcinoma (or comedo-adenoma) of the female breast. Am J Cancer, 1934, 22: 842-853.
[2]
Muir R. The evolution of carcinoma of the mamma. J Pathol Bacteriol, 1941, 52: 155-172.
[3]
Burstein JH, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast. N Engl J Med, 2004, 350(14): 1411-1430
[4]
Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvastion. Am J Surg, 2003, 186(2): 112-116.
[5]
Recht A, Th Rutgers EJ, Fentiman S, et al. The fourth EORTC DCIS consensus meeting (Château Marquette, Heemskerk, The Netherlands, 23-24 January 1998)-Conference report. Eur J Cancer, 1998, 34(11): 1664-1669.
[6]
[7]
Steinman S, Wang J, Bourne P, et al. Expression of cytokerat in markers, ER alpha, PR, HER2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with coexisting invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci, 2007, 37(2): 127-134.
[8]
Patani N, Khaled Y, Al Reefy S, Mokbel K. Ductal carcinoma in-situ: an update for clinical practice. Surg Oncol, 2011, 20(1): e23-31.
[9]
Skaane P, Young K, Skjennald A, et al. Population-based mammography screening:comparison of screen-film and full-filed digital mammography with soft-copyreading-Oslo Ⅰ study. Radiology, 2003, 29(3): 877-883.
[10]
Fischmann A, Siegmann KC, Wersebe A, et al. Comparison of full-field digital mammography and film-screen mammography: image quality and lesion detection. Radiology, 2005, 78(9): 312-317.
[11]
Feig SA. Ductal carcinoma in situ: implication for screening mammgraphy. Radiol Clin North Am, 2000, 38(4): 653-668.
[12]
Holland R, Hendriks JH. Microcalcification associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol, 1994, 11(3): 181-192.
[13]
Holland R, Hendriks JH, Vebeek AL, et al. Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet, 1990, 335(8688): 519-522.
[14]
Morakkabati-Spitz N, Leutner C, Schild H, et al. Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol2005, 15(90): 2010-2017.
[15]
胡静，汪登斌，姜婷婷, 等. 乳腺导管原位癌MRI特点分析. 外科理论与实践, 2010, 15(5): 112-116.
[16]
Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational studyLancet, 2007, 370(9586): 485-492.
PREV Breast MR imaging for distinguishing well-circumscribed breast malignancies from benign lesions
